Unknown

Dataset Information

MicroRNAs in the pathogenesis of Lung Cancer.


ABSTRACT: Lung cancer is the leading cause of cancer related deaths in the United States. It is estimated that in 2008 there were 215,000 new diagnoses of lung cancer and 163,000 deaths. Despite emerging technologies for potential early diagnosis and discovery of novel targeted therapies, the overall 5-year survival remains a disappointing 15%. Explanations for the poor survival include late presentation of disease, a lack of markers for early detection, and both phenotypic and genotypic heterogeneity within patients of similar histologic classification. To further understand this heterogeneity and thus complexity of lung cancer, investigators have applied various technologies including high throughput analysis of both the genome and proteome. Such approaches have been successful in identifying sign

SUBMITTER: Wu X 

PROVIDER: S-EPMC2723999 | biostudies-literature | 2009 Aug

REPOSITORIES: biostudies-literature